Track Archives:
Managing Non-Multiple Sclerosis Patients in a Multiple Sclerosis Practice: Rare Neuroimmunological Disorders – Everything You Need to Know Part 3
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This session will introduce participants to the biologic and clinical basics of rare neuroimmune conditions such as neuromyelitis optic, anti-MOG associated disorder, autoimmune encephalitis, myelitis, neurosarcoidosis and stiff person syndrome. Participants will be educated about diagnostic criteria and appropriate …
Advances in CSF Biomarkers for Multiple Sclerosis
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE The brain’s ‘soup’ or CSF is rich with information that may exude from processes within the CNS. It is once again an integral part of the new diagnostic criteria, but an alternative assay to the usual and tedious detection of CSF-specific IgG oligoclonal …
Continue reading “Advances in CSF Biomarkers for Multiple Sclerosis”
MS in Underserved Populations: Understanding Needs and Improving Outcomes
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Multiple sclerosis outcomes are influenced by far more than disease biology alone. Social determinants of health—including access to care, insurance coverage, transportation, employment, education, social support, and health system design—play a critical role in shaping when MS is diagnosed, …
Continue reading “MS in Underserved Populations: Understanding Needs and Improving Outcomes”
Spinal Cord Variants: Special Considerations in MS Diagnosis and Treatment
2026 Charlotte, NC sessions AAPA, CME, Letter of Completion, NCPD, IPCE This scientific session will examine emerging concepts in spinal cord (SC)-focused MS and demyelinating disease, highlighting how advances in pathology, imaging, and mechanistic understanding are reshaping traditional models of central nervous system demyelination. Particular attention will be given to the SC as a critical …
Continue reading “Spinal Cord Variants: Special Considerations in MS Diagnosis and Treatment”
Whitaker Platform Session
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This platform session will feature cutting-edge investigations from emerging and established researchers, highlighting novel insights into the biological mechanisms, biomarkers, and clinical manifestations of multiple sclerosis (MS). Presentations will explore accelerated aging in MS through neuroimaging and proteomic approaches, …
Malnutrition, Body Composition, and Frailty in MS
2026 Charlotte, NC sessions AAPA, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE Malnutrition is a multifaceted condition resulting from insufficient protein/energy balance that adversely affects body composition and physiological reserve. It can stem from disease-specific processes that have high energy demands including immune dysfunction and inflammation. As such, people with MS may …
Continue reading “Malnutrition, Body Composition, and Frailty in MS”
Disco and Beyond Disco with a Pharmacists’ Twist
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE This course will discuss the findings from Disco and a current study, Beyond Disco. This session will cover how to implement the findings from Disco in the clinic. The pharmacy session will discuss how to counsel patients on how to taper or reduce …
Continue reading “Disco and Beyond Disco with a Pharmacists’ Twist”
Community Wellness Program Models for People Living with MS
2026 Charlotte, NC sessions AAPA, ACPE, AOTA, APA, ASWB, CME, Letter of Completion, NCPD, RD, IPCE This Clinical Course would cover different models in delivering wellness for people living with MS. The course would highlight the type of information and interventions delivered to better form community and decrease social isolation. It would also highlight how …
Continue reading “Community Wellness Program Models for People Living with MS”
John Whitaker Lecture-The Illusion of Equivalence? Generic and Biosimilar Disease-Modifying Therapies in Multiple Sclerosis
2026 Charlotte, NC sessions AAPA, ACPE, CME, Letter of Completion, NCPD, IPCE Multiple sclerosis (MS) represents a spectrum of demyelinating presentations with varying degrees of inflammatory activity and symptom expression, affecting nearly one million individuals in the U.S. The use of Food and Drug Administration (FDA)-approved disease-modifying therapies (DMTs) aim to reduce risk for clinical …